ASX:MDR - Medadvisor Stock Price, News & Analysis

A$0.05
0.00 (0.00 %)
(As of 08/18/2019 09:41 AM ET)
Today's Range
A$0.05
Now: A$0.05
A$0.05
50-Day Range
A$0.05
MA: A$0.05
A$0.05
52-Week Range
A$0.03
Now: A$0.05
A$0.06
Volume634,544 shs
Average VolumeN/A
Market Capitalization$68.15 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A
MedAdvisor Limited develops and delivers software for personal medication management in Australia. It develops and deploys the MedAdvisor, a medication and adherence platform that connects health professionals with patients using mobile and Web technologies; and PlusOne, a software platform, which allow pharmacies to connect with patients via SMS, App, Web/email or Landline. MedAdvisor Limited is based in Camberwell, Australia.

Industry, Sector and Symbol

Industry Health Information Services
Sub-IndustryN/A
SectorComputer and Technology
CUSIPN/A
CIKN/A
PhoneN/A

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$7.23 million
Cash FlowA$0.00 per share
Book ValueA$0.01 per share

Profitability

Miscellaneous

EmployeesN/A
Outstanding Shares1,362,960,000
Market Cap$68.15 million
Next Earnings DateN/A
OptionableOptionable

Receive MDR News and Ratings via Email

Sign-up to receive the latest news and ratings for MDR and its competitors with MarketBeat's FREE daily newsletter.


Medadvisor (ASX:MDR) Frequently Asked Questions

What is Medadvisor's stock symbol?

Medadvisor trades on the ASX under the ticker symbol "MDR."

Has Medadvisor been receiving favorable news coverage?

Press coverage about MDR stock has trended negative recently, InfoTrie Sentiment Analysis reports. The research firm scores the sentiment of press coverage by reviewing more than six thousand blog and news sources in real time. The firm ranks coverage of public companies on a scale of -5 to 5, with scores closest to five being the most favorable. Medadvisor earned a daily sentiment score of -2.3 on InfoTrie's scale. They also assigned media coverage about the company a news buzz of 0.0 out of 10, indicating that recent press coverage is extremely unlikely to have an effect on the company's share price in the near term. View News Stories for Medadvisor.

Who are some of Medadvisor's key competitors?

Who are Medadvisor's key executives?

Medadvisor's management team includes the folowing people:
  • Mr. Robert Read BComm(Mgt), BA(Psych), GAICD, MD, CEO & Exec. Director
  • Mr. Joshua Swinnerton MEI, GradCert Eng., BE, BCS(Hons)., Founder, Chief Product Officer & Exec. Director
  • Mr. Carlo Campiciano, Company Sec. & CFO
  • Mr. Victor Kovalev, CTO & Head of Product
  • Jennifer Duraisingam, Corp. Communications Mang.

What is Medadvisor's stock price today?

One share of MDR stock can currently be purchased for approximately A$0.05.

How big of a company is Medadvisor?

Medadvisor has a market capitalization of $68.15 million and generates $7.23 million in revenue each year. View Additional Information About Medadvisor.

What is Medadvisor's official website?

The official website for Medadvisor is http://www.medadvisor.com.au/.


MarketBeat Community Rating for Medadvisor (ASX MDR)

Community Ranking:  2.5 out of 5 (star star half star)
Outperform Votes:  3 (Vote Outperform)
Underperform Votes:  3 (Vote Underperform)
Total Votes:  6
MarketBeat's community ratings are surveys of what our community members think about Medadvisor and other stocks. Vote "Outperform" if you believe MDR will outperform the S&P 500 over the long term. Vote "Underperform" if you believe MDR will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 8/18/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel